AT2_CROXC
ID AT2_CROXC Reviewed; 433 AA.
AC A0A2Z5CVK5;
DT 16-OCT-2019, integrated into UniProtKB/Swiss-Prot.
DT 10-OCT-2018, sequence version 1.
DT 03-AUG-2022, entry version 11.
DE RecName: Full=Myricetin 3-O-glucosyl 1,2-rhamnoside 6'-O-caffeoyltransferase AT2 {ECO:0000305};
DE EC=2.3.1.- {ECO:0000269|PubMed:29967287};
DE AltName: Full=Acyltransferase 2 {ECO:0000303|PubMed:29967287};
DE Short=CcAT2 {ECO:0000303|PubMed:29967287};
GN Name=AT2 {ECO:0000303|PubMed:29967287};
OS Crocosmia x crocosmiiflora (Montbretia) (Crocosmia aurea x Crocosmia
OS pottsii).
OC Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC Spermatophyta; Magnoliopsida; Liliopsida; Asparagales; Iridaceae;
OC Crocoideae; Freesieae; Crocosmia.
OX NCBI_TaxID=1053288;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND TISSUE
RP SPECIFICITY.
RX PubMed=29967287; DOI=10.1105/tpc.18.00406;
RA Irmisch S., Jo S., Roach C.R., Jancsik S., Man Saint Yuen M., Madilao L.L.,
RA O'Neil-Johnson M., Williams R., Withers S.G., Bohlmann J.;
RT "Discovery of UDP-glycosyltransferases and BAHD-acyltransferases involved
RT in the biosynthesis of the antidiabetic plant metabolite montbretin A.";
RL Plant Cell 30:1864-1886(2018).
CC -!- FUNCTION: Caffeoyltransferase involved in montbretin A (MbA)
CC biosynthesis (PubMed:29967287). Catalyzes the caffeoylation of
CC myricetin 3-O-beta-D-glucosyl 1,2-alpha-L-rhamnoside (MRG) to produce
CC myricetin 3-O-(6'-O-caffeoyl)-beta-D-glucosyl 1,2-alpha-L-rhamnoside
CC (mini-MbA), a precursor of MbA (PubMed:29967287). Mini-MbA and MbA are
CC potent inhibitors of human pancreatic alpha-amylase and are being
CC developed as drug candidates to treat type-2 diabetes
CC (PubMed:29967287). In vitro, is able to catalyze the caffeoylation of
CC quercetin 3-O-sophoroside (QGG), although QGG may not be a
CC physiological substrate in vivo (PubMed:29967287). In vitro, can use
CC coumaryl-CoA, feruloyl-CoA and acetyl-CoA, although these three acyl
CC donors may not be physiological in vivo (PubMed:29967287).
CC {ECO:0000269|PubMed:29967287}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=(E)-caffeoyl-CoA + myricetin 3-O-[beta-D-glucosyl-(1->2)-
CC alpha-L-rhamnoside] = CoA + myricetin 3-O-[(6-O-(E)-caffeoyl-beta-D-
CC glucosyl)-(1->2)-alpha-L-rhamnoside]; Xref=Rhea:RHEA:61152,
CC ChEBI:CHEBI:57287, ChEBI:CHEBI:87136, ChEBI:CHEBI:144428,
CC ChEBI:CHEBI:144429; Evidence={ECO:0000269|PubMed:29967287};
CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61153;
CC Evidence={ECO:0000269|PubMed:29967287};
CC -!- PATHWAY: Flavonoid metabolism. {ECO:0000305}.
CC -!- TISSUE SPECIFICITY: Expressed in young cromes.
CC {ECO:0000269|PubMed:29967287}.
CC -!- SIMILARITY: Belongs to the plant acyltransferase family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; MH365463; AXB26762.1; -; mRNA.
DR AlphaFoldDB; A0A2Z5CVK5; -.
DR SMR; A0A2Z5CVK5; -.
DR GO; GO:0016747; F:acyltransferase activity, transferring groups other than amino-acyl groups; IEA:UniProt.
DR Gene3D; 3.30.559.10; -; 2.
DR InterPro; IPR023213; CAT-like_dom_sf.
PE 1: Evidence at protein level;
KW Acyltransferase; Transferase.
FT CHAIN 1..433
FT /note="Myricetin 3-O-glucosyl 1,2-rhamnoside 6'-O-
FT caffeoyltransferase AT2"
FT /id="PRO_0000448220"
FT ACT_SITE 157
FT /note="Proton acceptor"
FT /evidence="ECO:0000250|UniProtKB:Q8W1W9"
FT ACT_SITE 375
FT /note="Proton acceptor"
FT /evidence="ECO:0000250|UniProtKB:Q8W1W9"
SQ SEQUENCE 433 AA; 48138 MW; E936D485E98C15B8 CRC64;
MSFTVTKTAP AVITPSEPTP SGHILPLSFF DRLPFLRVFL VDMIMVYGHG DQPAKVIKEA
VAKALVHYYP LAGRLTTDTD DGELSVACTG EGVWFVEATA DCRMEDVNYL QVEPLMIPKE
QILPSHPEGV DPYTLPFMIQ VTQFRCGGFT FATRANHAVF DGIGAGQIKV AIGEMARGLK
HPTVKPVWCR DVIRKPIPSQ ISATEPHDTD LSSIPDLKFT NNQTNIECCS FDLSLDHINH
LKDHFAKEVG KICSVFDVIA AKLWQSRTRA IGLQPQTEVS LTFLLNIRQV VLHNELPPDG
GYYGNCLVPL INKAPSGQIA NAPLFEIVRL IKEAKDDLLS KDSASLIGEM PPYKKPSYAD
LSIVDWRRLG LYEADFGWGG PMFLVPLNEH TVTSCSTYLF KSPVASKKDV RLVTYCIVKE
HLEAFRDEMN DFT